The bite or sting of a highly venomous animal can inflict great suffering, including loss of limbs, paralysis, and an extremely painful death. In the United States, envenomation (the injection of ...

Bispecific T-cell engager (BiTE) antibodies have shown efficacy in hematological malignancies and are being tested in a variety of solid tumors. Other strategies including bispecific antibodies in ...

Their painful bites contain a cocktail of chemicals, primarily the highly conserved alpha-latrotoxin (α-LTX). This toxin induces latrodectism, an illness causing severe pain. Horse-derived antibodies ...

Blinatumomab is the company's lead molecule using the bispecific T cell engager (BiTE) antibody technology, a new approach within immunotherapy, currently one of the most exciting area of oncology ...

Developed at the UW Institute of Protein Design, deep learning models were used to design proteins "not found in nature" that ...

“I think this is a really huge step in terms of what can be achieved by a single antibody.” Venomous snake bites claim the lives of an estimated 81,000 to 138,000 people annually and leave ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...